Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Global Neurological Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... 2022 and is forecast to a readjusted size of USD 196010 million by 2029 with a CAGR of 7.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market ... Read More
-
Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 22.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028. Depression is a mental disorder characterized by the absence of positive emotions, constant low mood and numerous cognitive, physical, behavioral ... Read More
-
North America Hormone Replacement Therapy Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5% during 2023-2028. Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in ... Read More
-
Global Neurological Drugs Supply, Demand and Key Producers, 2023-2029
... period (2023-2029). Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction. This report studies the global ... Read More
-
Global Wilson's Disease Drugs Market 2023-2027
... Wilson's disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
REAGILA Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Nedosiran Emerging Drug Insight and Market Forecast − 2032
... picture of the nedosiran for primary hyperoxaluria in the 7MM, i.e., United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
2023 Global Forecast for Parkinson'S Disease Treatment Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2023 Global Forecast for Pharmacy Automation Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
COPD Treatment
... breathing problems. These include emphysema and chronic bronchitis. The rising prevalence of COPD, primarily due to factors like smoking, air pollution, and ageing populations, is the driving factor for the market growth of the COPD ... Read More
-
2023 Global Forecast for Pain Management Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
ALLO-ASC-DFU Emerging Drug Insight and Market Forecast − 2032
... of the ALLO-ASC-DFU for chronic wounds in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
ABILIFY MYCITE Drug Insight and Market Forecast − 2032
... of the ABILIFY MYCITE for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
2023 Global Alzheimer'S Disease Drug Market Industry (2029 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include ... Read More
-
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Diabetes is a chronic condition brought on by insufficient levels of either insulin synthesis or insulin use. It poses a significant public health challenge and is among the priority communicable diseases targeted by world leaders. ... Read More
-
Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast – 2032
... desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinued. In 2022, the highest number of diagnosed prevalent cases of Opioid Use Disorder (OUD) was observed in the United States among the 7MM. ... Read More
-
Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030
... is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by ... Read More
-
Pitolisant Emerging Drug Insight and Market Forecast − 2032
... of the pitolisant for myotonic dystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Vietnam Pharmaceutical Market Outlook to 2027
... offers opportunities for both domestic and international pharmaceutical companies, with a focus on generic drugs and an increasing emphasis on research and development. With a population of over 98 Mn and a growing affluent class, ... Read More
-
2023 Global Anti-Acne Serum Industry (2029 Outlook)
... reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of ... Read More
-
RPL554 Emerging Drug Insight and Market Forecast − 2032
... of the RPL554 for cystic fibrosis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
KALYDECO Drug Insight and Market Forecast − 2032
... KALYDECO for cystic fibrosis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this report along with a ... Read More
-
CAPLYTA Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Avexitide Emerging Drug Insight and Market Forecast − 2032
... picture of the avexitide for CHI in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
OXLUMO Drug Insight and Market Forecast − 2032
... the OXLUMO for primary hyperoxaluria in the 6MM, i.e., United States, EU4 (Germany, France, Italy, Spain), the United Kingdom for the study period 2019 –2032 is provided in this report along with a detailed description ... Read More
Research Assistance
